Rezolute (RZLT) Profit After Tax (2010 - 2026)
Rezolute (RZLT) reported Profit After Tax of -$16.3 million for Q1 2026, up 13.65% on a YoY basis from -$14.4 million in Q1 2025, and up 28.29% sequentially from -$22.8 million in Q4 2025.
Rezolute (RZLT) Profit After Tax (2010 - 2026) Analysis & Trends
Rezolute (RZLT) has 17 years of Profit After Tax data on file, last reported at -$16.3 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax rose 13.65% year-over-year to -$16.3 million; the trailing twelve-month figure through Mar 2026 stood at -$81.8 million (down 12.99% YoY), and the FY2025 full-year result was -$74.4 million, down 9.11% from the prior year.
- Profit After Tax advanced to -$16.3 million in Q1 2026, from -$22.8 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$9.4 million in Q2 2022 to a low of -$24.5 million in Q2 2025.
- A 5-year average of -$16.0 million and a median of -$15.7 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax tumbled 203.33% in 2022 and climbed 13.65% in 2026, its largest moves.
- Tracing RZLT's Profit After Tax over 5 years: stood at -$13.6 million in 2022, then declined by 0.86% to -$13.7 million in 2023, then slipped by 15.04% to -$15.7 million in 2024, then tumbled by 44.79% to -$22.8 million in 2025, then climbed by 28.29% to -$16.3 million in 2026.
- Business Quant data shows RZLT's Profit After Tax at -$16.3 million in Q1 2026, -$22.8 million in Q4 2025, and -$18.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Rezolute | 518.12 Mn | 518.12 Mn | - | -16.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.33 Mn |
| Dec 31, 2025 | -22.78 Mn |
| Sep 30, 2025 | -18.15 Mn |
| Jun 30, 2025 | -24.50 Mn |
| Mar 31, 2025 | -18.91 Mn |
| Dec 31, 2024 | -15.73 Mn |
| Sep 30, 2024 | -15.01 Mn |
| Jun 30, 2024 | -22.70 Mn |
| Mar 31, 2024 | -17.05 Mn |
| Dec 31, 2023 | -13.67 Mn |
| Sep 30, 2023 | -14.52 Mn |
| Jun 30, 2023 | -12.60 Mn |
| Mar 31, 2023 | -15.80 Mn |
| Dec 31, 2022 | -13.56 Mn |
| Sep 30, 2022 | -9.83 Mn |
| Jun 30, 2022 | -9.42 Mn |
| Mar 31, 2022 | -11.21 Mn |
| Dec 31, 2021 | -12.59 Mn |
| Sep 30, 2021 | -7.84 Mn |
| Jun 30, 2021 | -6.49 Mn |